Kangmei Pharmaceutical Co (SHSE:600518) Construction In Progress : ¥173 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Kangmei Pharmaceutical Co Construction In Progress?

Kangmei Pharmaceutical Co's quarterly construction in progress declined from Sep. 2023 (¥213 Mil) to Dec. 2023 (¥211 Mil) and declined from Dec. 2023 (¥211 Mil) to Mar. 2024 (¥173 Mil).

Kangmei Pharmaceutical Co's annual construction in progress declined from Dec. 2021 (¥264 Mil) to Dec. 2022 (¥216 Mil) and declined from Dec. 2022 (¥216 Mil) to Dec. 2023 (¥211 Mil).

Kangmei Pharmaceutical Co Construction In Progress Historical Data

The historical data trend for Kangmei Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangmei Pharmaceutical Co Construction In Progress Chart

Kangmei Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

3,714.32

1,629.98

263.65

215.50

210.56

Kangmei Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															216.55	210.01	213.27	210.56	173.17

Kangmei Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Kangmei Pharmaceutical Co (SHSE:600518) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kangmei Pharmaceutical Co Ltd (SHSE:600518) » Definitions » Construction In Progress

Traded in Other Exchanges

N/A

Address

No. 3, Taike Road, Xiameilin, Futian District, Shenzhen, CHN, 518000

Website

http://www.kangmei.com.cn

Kangmei Pharmaceutical Co Ltd is a pharmaceutical company engaged in the manufacturing, research and marketing of herbal medicine and chemical raw materials.

Executives

Xu Dong Jin	Director
Li Jian Hua	senior management
Qiu Xi Wei	Director
Wang Min	senior management
Peng Qin	senior management
Ma Xing Tian	Director
Lin Guo Xiong	senior management
Zhuang Yi Qing	senior management
Wen Shao Sheng	Supervisors

Kangmei Pharmaceutical Co (SHSE:600518) Headlines

No Headlines